本帖最后由 成长的烦恼 于 2012-6-27 20:19 编辑
. |) |+ X5 K' q8 a: k& C
; `5 z' R$ O( _" n8 x2 mclinicaltrials上的三期临床链接
4 Z D& `. N: u9 m+ _
' ]; g: H! W* G% I. _http://clinicaltrials.gov/ct2/sh ... mp;show_locs=Y#locn
6 @& g+ q1 A, \: X. h- K- N
+ s E6 R i1 N5 M3 @中国参加临床实验的城市9 z/ ]$ H6 m+ i3 `5 ], I6 }
" Q% H% Y) P& ]8 u! ^) _
China, Guangdong C& z, y" q+ l: O. G% s0 k
- ?6 d c1 R9 a% L7 J& A4 W9 Q4 SGuangzhou, Guangdong, China, 510515
, ~, f/ o/ \) V! u
1 C1 n$ e @5 Q: O) L/ q4 F% [Guangzhou, Guangdong, China, 510060
5 B% m7 m# i4 z- |" z; H8 MChina, Jiangsu
9 K3 J8 u" ^4 N3 d0 S! Y+ p
# H# f! W% A6 u$ fNanjing, Jiangsu, China, 210009
$ R; P4 P6 |9 A$ X' E
4 k) A* c% U9 B6 X* ?Nanjing, Jiangsu, China, 210002 ) l# L+ n' `! z {& i
China, Shandong o; J# S0 H# {2 X$ e
( J5 B" b9 ?6 V3 b& H5 |
Qingdao, Shandong, China, 266003
+ { [- w* g0 @China ( T7 T4 u$ x+ Z1 e" k) j! X
. Z, N8 G9 j4 m6 WBeijing, China, 100021
3 M8 Q4 S# O/ }5 R$ H# Q) o4 X/ E
+ Y* v0 E$ v# z0 F+ e% x# nBeijing, China, 100071
( B3 h2 ^# v9 _9 u2 s4 P* w* f. ]
( }- q }$ S7 r3 i, `8 H4 OChangchun, China, 130021
& _ e2 e! r3 o) U( ]
/ {# p4 r8 _& \+ F" f# BChongqing, China, 400042 ; C& ]% B9 I; q) N8 W$ O2 L" m3 A0 }
) T+ c$ h, i) i2 ^% S! q# WChongqing, China, 400038
6 p0 P1 \2 w5 S
+ l, ]7 t% F' A% d: G9 O0 }* l6 _' dFuzhou, China, 350014 % x5 n L) s9 { u
( m- d8 Q- s' W) IFuzhou, China, 350025
* K% Q& X- Q5 l! c: C; @
- p5 t# R) I; s' K+ SHa'erbin, China, 150040 $ h7 M" ]/ ] ]5 ~6 N* y0 p
2 b7 _* W1 r H* J; I
Hanghzou, China, 310009 # l9 E+ w! `/ D- w
4 T. |8 |8 I" G) P- d5 U" \/ ]" f ]
Shanghai, China, 200001 " v" Z5 e d& k6 I0 {' }
5 V, H! Q+ Z1 \& f) ^Shanghai, China, 200030
6 g9 j8 T$ ^5 S6 ]9 W& T1 U ( n+ u. f0 z* a- _: j6 [1 B0 L
Tianjin, China 4 w$ ]# d5 I w- F
& o! G( U' Z* B$ \( @3 G该实验已停止招募,重新开的临床请见临床专用贴。 |